Skip to content

Innoviva, Inc. INVA Investing Cash Flow

Investing Cash Flow at other companies

Pfizer logo
PfizerPFE
$785M-76.0%
Merck & Co. logo
Merck & Co.MRK
-$10.21B-587%
AbbVie logo
AbbVieABBV
-$574M+21.9%
Insmed logo
InsmedINSM
$265.52M+230%
Savara logo
SavaraSVRA
$38.78M+32.2%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$3.58M-90.3%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s investing cash flow?
Innoviva, Inc. (INVA) reported investing cash flow of $37.01M in Q1 2026.
How has Innoviva, Inc.'s investing cash flow changed year-over-year?
Innoviva, Inc.'s investing cash flow increased by 206.7% year-over-year, from -$34.67M to $37.01M.
What is the long-term trend for Innoviva, Inc.'s investing cash flow?
Over 2 years (2023 to 2025), Innoviva, Inc.'s investing cash flow has grown at a -22.1% compound annual growth rate (CAGR), from -$66.76M to $40.5M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.